BRIEF published on 04/07/2026 at 18:05, 5 months 18 days ago Oxurion reporte son Assemblée Générale Annuelle Assemblée Générale Report Actifs Numériques Pharmaceutique Oxurion
BRIEF published on 04/07/2026 at 18:05, 5 months 18 days ago Oxurion Postpones Annual Shareholders Meeting Financial Calendar Shareholders Meeting Investment Risks Oxurion Pharmaceutical Outsourcing
BRIEF published on 04/07/2026 at 18:05, 5 months 18 days ago Oxurion postpones its Annual General Meeting Pharmaceutical Digital Assets General Assembly Report Oxurion
PRESS RELEASE published on 04/07/2026 at 18:00, 5 months 18 days ago Uitstel Gewone Algemene Vergadering Oxurion NV kondigt uitstel van de Jaarlijkse Vergadering van Aandeelhouders aan vanwege niet gefinaliseerde jaarrekening. Het bedrijf specialiseert zich in farmaceutische onderaannemers. Gevestigd in Leuven, België Oxurion NV Leuven Uitstel Jaarlijkse Vergadering Farmaceutisch
PRESS RELEASE published on 04/07/2026 at 18:00, 5 months 18 days ago Postponement Annual Shareholders Meeting Oxurion NV postpones Annual Shareholders Meeting to June 1st, 2026 due to pending annual accounts. The pharmaceutical outsourcing company specializes in acquiring European subcontractors. Forward-looking statements in press release Forward-looking Statements Postponement Oxurion NV Pharmaceutical Outsourcing European Subcontractors
BRIEF published on 03/19/2026 at 18:35, 6 months 6 days ago Oxurion annonce son intention d'acquérir une CRO internationale Acquisition Expansion Internationale Recherche Clinique Pharmaceutique Oxurion
BRIEF published on 03/19/2026 at 18:35, 6 months 6 days ago Oxurion Announces Intent to Acquire International CRO Acquisition Clinical Research Pharmaceutical International Expansion Oxurion
BRIEF published on 03/19/2026 at 18:35, 6 months 6 days ago Oxurion projette l'acquisition d'une CRO internationale Acquisition Stratégie De Croissance Développement Clinique Oxurion CRO Internationale
BRIEF published on 03/19/2026 at 18:35, 6 months 6 days ago Oxurion plans to acquire an international CRO Growth Strategy Acquisition Clinical Development Oxurion International CRO
PRESS RELEASE published on 03/19/2026 at 18:30, 6 months 6 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
Published on 09/26/2026 at 01:00, 12 hours 57 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 12 hours 57 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 15 hours 42 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 20 hours 27 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 22 hours 57 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 07:45, 6 hours 11 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 13 hours 55 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 19 hours 27 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 19 hours 57 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:45, 20 hours 12 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 20 hours 17 minutes ago Availability of the 2026 half-year financial report
